May 11, 2010
The FDA's Division of Drug Marketing, Advertising, and Communications (DDMAC) has launched the Bad Ad Program, designed to educate healthcare providers about their role in ensuring that prescription drug advertising and promotion is truthful, and not misleading.
February 03, 2010
The FDA has approved Medicis' hyaluronic acid with lidocaine dermal fillers, Restylane-L and Perlane-L.
February 02, 2010
The FDA has approved Juvéderm XC (hyaluronic acid and lidocaine [preservative-free] injectable gel, from Allergan) dermal filler for injection into the mid-to-deep dermis for correction of moderate to severe facial wrinkles and folds (eg, nasolabial folds).
August 03, 2009
Medivir has received approval to market Lipsovir (hydrocortisone and acyclovir, cream) for the topical treatment of cold sores in patients ≥12 years of age.
July 28, 2009
Promiseb topical cream, a nonsteroidal cream with antiinflammatory and antifungal properties, has been made available by Promius Pharma for the treatment of seborrheic dermatitis.